Davis, S.L.; Messersmith, W.A.; Purcell, W.T.; Lam, E.T.; Corr, B.R.; Leal, A.D.; Lieu, C.H.; O’Bryant, C.L.; Smoots, S.G.; Dus, E.D.;
et al. A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers 2024, 16, 1456.
https://doi.org/10.3390/cancers16081456
AMA Style
Davis SL, Messersmith WA, Purcell WT, Lam ET, Corr BR, Leal AD, Lieu CH, O’Bryant CL, Smoots SG, Dus ED,
et al. A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers. 2024; 16(8):1456.
https://doi.org/10.3390/cancers16081456
Chicago/Turabian Style
Davis, S. Lindsey, Wells A. Messersmith, W. Thomas Purcell, Elaine T. Lam, Bradley R. Corr, Alexis D. Leal, Christopher H. Lieu, Cindy L. O’Bryant, Stephen G. Smoots, Evan D. Dus,
and et al. 2024. "A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors" Cancers 16, no. 8: 1456.
https://doi.org/10.3390/cancers16081456
APA Style
Davis, S. L., Messersmith, W. A., Purcell, W. T., Lam, E. T., Corr, B. R., Leal, A. D., Lieu, C. H., O’Bryant, C. L., Smoots, S. G., Dus, E. D., Jordan, K. R., Serkova, N. J., Pitts, T. M., & Diamond, J. R.
(2024). A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers, 16(8), 1456.
https://doi.org/10.3390/cancers16081456
